The Prognostic Value of Cardiac Troponin in a Revascularized Cohort with First-Time Myocardial Infarction
In this revascularized cohort surviving a first-time MI, the magnitude of peak troponin elevation was not associated with all-cause death or cardiovascular readmission.
Authors
- Helen Wihongi (ORCID: https://orcid.org/0000-0001-6801-6955)
- Nikki Earle (ORCID: https://orcid.org/0000-0003-1663-2195)
- Thomas Lumley (ORCID: https://orcid.org/0000-0003-4255-5437)
- Gerry Devlin (ORCID: https://orcid.org/0009-0005-6545-6724)
- Anna K Rolleston (ORCID: https://orcid.org/0000-0002-4804-8869)
- Ralph Stewart (ORCID: https://orcid.org/0000-0002-6167-1225)
- Kimiora Henare (ORCID: https://orcid.org/0000-0001-5113-0700)
- Andrew Kerr (ORCID: https://orcid.org/0000-0001-8310-6289)
- Anna P. Pilbrow (ORCID: https://orcid.org/0000-0003-1949-9449)
- Malcolm E. Legget (ORCID: https://orcid.org/0000-0002-1449-8183)
- Vicky A. Cameron (ORCID: https://orcid.org/0000-0003-3147-683X)
- Katrina Poppe (ORCID: https://orcid.org/0000-0002-4418-4476)
- Robert N. Doughty
- Graeme Porter
- Gerald L. Logue
Institutions
- University of Auckland (NZ)
- Middlemore Hospital (NZ)
- Auckland City Hospital (NZ)
- The Centre for Health (New Zealand) (NZ)
- Tauranga Hospital (NZ)
- Waitemata District Health Board (NZ)
- Cancer Society of New Zealand (NZ)
- University of Otago (NZ)
Publication Details
- Journal
- Cardiology
- Published
- 2025-08-28
- DOI
- https://doi.org/10.1159/000548210
- Primary Topic
- Acute Myocardial Infarction Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00